Top shareholders of NBTX - Nanobiotix S.A. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with the largest verified stakes, then open the linked filing trail.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Nanobiotix S.A. - Common Stock (NBTX) as of Q4 2020
As of 31 Dec 2020,
Nanobiotix S.A. - Common Stock (NBTX) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,926,653 shares.
The largest 10 holders included
BAILLIE GIFFORD & CO, PERCEPTIVE ADVISORS LLC, Artal Group S.A., TYBOURNE CAPITAL MANAGEMENT (HK) LTD, ORBIMED ADVISORS LLC, Woodline Partners LP, MILLENNIUM MANAGEMENT LLC, CITADEL ADVISORS LLC, Monashee Investment Management LLC, and MORGAN STANLEY.
This page lists
11
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
Investor
Option
Weight %
Change %
Value $
* Price
Shares
Share Change
Activity
Report Period
Compare Q4 2020 vs Q4 2025 Across Filers
Q4 2025 holders
14
Q4 2020 holders
11
Holder diff
-3
Investor
Q4 2025 Shares
Q4 2020 Shares
Share Diff
Share Chg %
Q4 2025 Value $
Q4 2020 Value $
Value Diff $
Value Chg %
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and, if you allow them, measure engagement and deliver
advertising. Analytics and marketing storage stay off until you grant
consent. By clicking on "Agree and continue", you declare your consent to
the use of the selected optional cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.